Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Svetlana Bureeva

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|January 25, 2011
Quantitative knowledge-based analysis in compound safety assessmentSvetlana Bureeva, Yuri Nikolsky
Methods in Molecular Biology (Clifton, N.J.)|September 4, 2009
Network and pathway analysis of compound-protein interactionsRichard J Brennan, Tatiana Nikolskya, Svetlana Bureeva
Drug Discovery Today|November 1, 2005
Drug design using the example of the complement system inhibitors' developmentSvetlana Bureeva, Julian Andia-Pravdivy, Alexander Kaplun
Methods in Molecular Biology (Clifton, N.J.)|July 15, 2009
Manual annotation of protein interactionsSvetlana Bureeva, Svetlana Zvereva, Valentin Romanov, et al.
BMC Bioinformatics|February 14, 2013
Discovery of novel biomarkers and phenotypes by semantic technologiesCarlo A Trugenberger, Christoph Wälti, David Peregrim, et al.
Plos One|April 18, 2013
Drug target prediction and repositioning using an integrated network-based approachDorothea Emig, Alexander Ivliev, Olga Pustovalova, et al.
Bioorganic & Medicinal Chemistry|January 27, 2005
Inhibition of classical pathway of complement activation with negative charged derivatives of bisphenol A and bisphenol disulphatesSvetlana Bureeva, Julian Andia-Pravdivy, Gennadiy Petrov, et al.
Chemical Biology & Drug Design|May 16, 2012
Prediction of organ toxicity endpoints by QSAR modeling based on precise chemical-histopathology annotationsEugene Myshkin, Richard Brennan, Tatiana Khasanova, et al.
Bioorganic & Medicinal Chemistry|March 27, 2007
Selective inhibition of the interaction of C1q with immunoglobulins and the classical pathway of complement activation by steroids and triterpenoids sulfatesSvetlana Bureeva, Julian Andia-Pravdivy, Andrey Symon, et al.
Journal of Cancer|May 23, 2015
Reconstitution of the ERG Gene Expression Network Reveals New Biomarkers and Therapeutic Targets in ERG Positive Prostate TumorsAlexey Dubovenko, Tatiana Serebryiskaya, Yuri Nikolsky, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Expert Opinion on Drug Metabolism & Toxicology|January 25, 2011
Quantitative knowledge-based analysis in compound safety assessmentSvetlana Bureeva, Yuri Nikolsky
Methods in Molecular Biology (Clifton, N.J.)|September 4, 2009
Network and pathway analysis of compound-protein interactionsRichard J Brennan, Tatiana Nikolskya, Svetlana Bureeva
Drug Discovery Today|November 1, 2005
Drug design using the example of the complement system inhibitors' developmentSvetlana Bureeva, Julian Andia-Pravdivy, Alexander Kaplun
Methods in Molecular Biology (Clifton, N.J.)|July 15, 2009
Manual annotation of protein interactionsSvetlana Bureeva, Svetlana Zvereva, Valentin Romanov, et al.
BMC Bioinformatics|February 14, 2013
Discovery of novel biomarkers and phenotypes by semantic technologiesCarlo A Trugenberger, Christoph Wälti, David Peregrim, et al.
Plos One|April 18, 2013
Drug target prediction and repositioning using an integrated network-based approachDorothea Emig, Alexander Ivliev, Olga Pustovalova, et al.
Bioorganic & Medicinal Chemistry|January 27, 2005
Inhibition of classical pathway of complement activation with negative charged derivatives of bisphenol A and bisphenol disulphatesSvetlana Bureeva, Julian Andia-Pravdivy, Gennadiy Petrov, et al.
Chemical Biology & Drug Design|May 16, 2012
Prediction of organ toxicity endpoints by QSAR modeling based on precise chemical-histopathology annotationsEugene Myshkin, Richard Brennan, Tatiana Khasanova, et al.
Bioorganic & Medicinal Chemistry|March 27, 2007
Selective inhibition of the interaction of C1q with immunoglobulins and the classical pathway of complement activation by steroids and triterpenoids sulfatesSvetlana Bureeva, Julian Andia-Pravdivy, Andrey Symon, et al.
Journal of Cancer|May 23, 2015
Reconstitution of the ERG Gene Expression Network Reveals New Biomarkers and Therapeutic Targets in ERG Positive Prostate TumorsAlexey Dubovenko, Tatiana Serebryiskaya, Yuri Nikolsky, et al.
Pageof 2